Guangzhou Baiyunshan Overview
- Year Founded
-
1997
- Status
-
Public
- Employees
-
27,057
- Stock Symbol
-
600332
- Investments
-
8
- Share Price
-
$2.88
- (As of Friday Closing)
Guangzhou Baiyunshan General Information
Description
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is engaged in the pharmaceutical and healthcare industry, focusing on the development of a full industrial chain covering research, manufacturing, and distribution. The group operates through five reportable segments. The Modern Chinese Medicine segment involves the R&D, manufacturing, and sale of proprietary Chinese and natural medicines. The Chemical Pharmaceutical Technology segment focuses on chemical drugs, APIs, and intermediates. The Natural Beverages segment produces and sells health-oriented beverage products. The Pharmaceutical Commerce segment is engaged in the wholesale, retail, and import/export of medicines and medical devices. The Other Segments include biotechnology innovation, consumer health, and medical services.
Contact Information
Website
www.gybys.com.cnCorporate Office
- 45 ShaMian North Street, Liwan District
- Liwan District
- Guangzhou, Guangdong 510130
- China
Corporate Office
- 45 ShaMian North Street, Liwan District
- Liwan District
- Guangzhou, Guangdong 510130
- China
Guangzhou Baiyunshan Stock Performance
As of 20-Nov-2026, Guangzhou Baiyunshan’s stock price is $2.88. Its current market cap is $4.4B with 1.63B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.88 | $2.91 | $2.84 - $3.75 | $4.4B | 1.63B | 7.42M | $0.19 |
Guangzhou Baiyunshan Financials Summary
As of 30-Sep-2026, Guangzhou Baiyunshan has a trailing 12-month revenue of $11.3B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 5,792,369 | 6,312,867 | 5,801,887 | 5,433,309 |
| Revenue | 11,334,637 | 10,798,589 | 10,451,291 | 10,673,736 |
| EBITDA | 435,601 | 673,642 | 626,673 | 848,041 |
| Net Income | 314,044 | 414,821 | 395,166 | 573,251 |
| Total Assets | 13,010,556 | 12,078,714 | 11,189,383 | 11,086,375 |
| Total Debt | 2,841,971 | 2,188,927 | 1,903,652 | 1,685,915 |
Guangzhou Baiyunshan Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Guangzhou Baiyunshan Signals
Guangzhou Baiyunshan Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Guangzhou Baiyunshan Investments & Acquisitions (8)
Guangzhou Baiyunshan’s most recent deal was a Merger/Acquisition with Pharmaceutical Industry for . The deal was made on 03-Mar-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Pharmaceutical Industry | 03-Mar-2026 | Merger/Acquisition | Distributors (Healthcare) | ||
| Zhejiang Medicine | 03-Mar-2026 | Merger/Acquisition | Pharmaceuticals | ||
| Hangrun Tech | 23-May-2024 | Later Stage VC | Aerospace and Defense | ||
| Guangzhou Pharmaceuticals | 15-Dec-2022 | Secondary Transaction - Private | Distributors (Healthcare) | ||
| Wanglaoji | 01-Sep-2018 | Merger/Acquisition | Pharmaceuticals |
Guangzhou Baiyunshan ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
18.07 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Distribution
Subindustry
of 42
Rank
Percentile
Guangzhou Baiyunshan Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Pharmaceutical Industry | Hangzhou, China | 1999 | |
| Zhejiang Medicine | Shaoxing, China | 1997 | |
| Wanglaoji | Guangzhou, China | 1992 |
Guangzhou Baiyunshan FAQs
-
When was Guangzhou Baiyunshan founded?
Guangzhou Baiyunshan was founded in 1997.
-
Where is Guangzhou Baiyunshan headquartered?
Guangzhou Baiyunshan is headquartered in Guangzhou, China.
-
What is the size of Guangzhou Baiyunshan?
Guangzhou Baiyunshan has 27,057 total employees.
-
What industry is Guangzhou Baiyunshan in?
Guangzhou Baiyunshan’s primary industry is Pharmaceuticals.
-
Is Guangzhou Baiyunshan a private or public company?
Guangzhou Baiyunshan is a Public company.
-
What is Guangzhou Baiyunshan’s stock symbol?
The ticker symbol for Guangzhou Baiyunshan is 600332.
-
What is the current stock price of Guangzhou Baiyunshan?
As of 20-Nov-2026 the stock price of Guangzhou Baiyunshan is $2.88.
-
What is the current market cap of Guangzhou Baiyunshan?
The current market capitalization of Guangzhou Baiyunshan is $4.4B.
-
What is Guangzhou Baiyunshan’s current revenue?
The trailing twelve month revenue for Guangzhou Baiyunshan is $11.3B.
-
What is Guangzhou Baiyunshan’s annual earnings per share (EPS)?
Guangzhou Baiyunshan’s EPS for 12 months was $0.19.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process